Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kyverna Therapeutics (KYTX) Q2 2025 Earnings
KYTX
13
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.13
-0.97
-0.82
-0.67
Details
Expected EPS
-1.125719
Actual EPS
-1.03
Surprise EPS
0.1
Surprise Percent
+8.5%
Description
Kyverna Therapeutics (KYTX) has reported earnings of -1.03 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login